How should a child with Axenfeld‑Rieger syndrome be evaluated and managed for ocular and systemic manifestations?

Evaluation and Management of Axenfeld-Rieger Syndrome in Children

Children with Axenfeld-Rieger syndrome require immediate comprehensive ophthalmologic evaluation at diagnosis, followed by multidisciplinary systemic screening for associated anomalies, with lifelong glaucoma surveillance as the primary priority to prevent irreversible vision loss.

Immediate Ophthalmologic Evaluation

Essential Ocular Examination Components

The initial eye examination must include 1:

• Binocular red reflex (Brückner) test - performed before dilation to detect asymmetry or opacities
• Slit-lamp examination for:
  • Posterior embryotoxon (prominent Schwalbe's line)
  • Iris abnormalities: corectopia (pupil displacement), polycoria (multiple pupils), iris hypoplasia, or iris strands to cornea
  • Iridocorneal angle dysgenesis with peripheral anterior synechiae
• Intraocular pressure (IOP) measurement - critical as 50% develop glaucoma 2, 3
• Gonioscopy to evaluate iridocorneal angle abnormalities
• Cycloplegic refraction - high refractive errors are common 4
• Dilated fundus examination with indirect ophthalmoscopy
• Visual acuity assessment (age-appropriate method)
• Binocular alignment testing to detect strabismus and amblyopia risk

Critical Pitfall

Patients with iris hypoplasia have significantly higher glaucoma risk - 50% of those with iris hypoplasia develop glaucoma 5. These children require more intensive monitoring.

Glaucoma Surveillance Protocol

Approximately 50% of ARS patients develop secondary glaucoma, making this the most vision-threatening complication 2, 3, 6.

Timing of Glaucoma Onset

• ARS is diagnosed within the first year of life in approximately half of patients 3
• Glaucoma onset is typically juvenile (childhood to early adulthood)
• FOXC1-related ARS shows earlier glaucoma onset than PITX2-related ARS 7

Monitoring Schedule

• Immediate IOP measurement at diagnosis
• Regular IOP monitoring every 3-6 months throughout childhood and lifelong
• More frequent monitoring if IOP elevation detected or if iris hypoplasia present 5

Comprehensive Systemic Evaluation

All children with ARS require systematic screening for extraocular manifestations, as systemic anomalies occur in nearly all PITX2-related cases and the majority of FOXC1-related cases 7.

Gene-Specific Systemic Manifestations

PITX2-Related ARS (if genetic testing confirms) 7:

• Umbilical anomalies (redundant periumbilical skin, umbilical hernia)
• Dental anomalies: microdontia, hypodontia, oligodontia, anodontia
• Meckel diverticulum (newly recognized high rate)
• Craniofacial dysmorphism: maxillary hypoplasia, flat nasal bridge, hypertelorism

FOXC1-Related ARS (if genetic testing confirms) 7:

• Hearing loss (sensorineural, partial or complete) - requires audiology referral
• Congenital heart defects - requires cardiology evaluation with echocardiogram
• Dental enamel hypoplasia and/or crowding
• Skeletal/joint anomalies
• Neurological features:
  • White matter hyperintensities (highly penetrant)
  • Colpocephaly/ventriculomegaly
  • Arachnoid cysts
  • Requires brain MRI
• Hypotonia/developmental delay
• Feeding disorders with potential structural esophageal anomalies
• Craniofacial features: maxillary hypoplasia, hypertelorism

Required Specialist Referrals 2, 3, 7:

1. Pediatric dentist/orthodontist - early referral as dental anomalies may require treatment in first dentition 3
2. Pediatric cardiologist - echocardiogram to evaluate for congenital heart defects (especially FOXC1-related)
3. Audiologist - hearing assessment (especially FOXC1-related)
4. Pediatric neurologist - if developmental delay or neurological concerns
5. Genetics specialist - for genetic testing (PITX2 and FOXC1 mutations account for 40% of cases) and family counseling 6
6. Pediatric gastroenterologist - if feeding difficulties or concern for Meckel diverticulum

Imaging Studies 7:

• Brain MRI - particularly for FOXC1-related ARS to evaluate white matter changes, ventriculomegaly, arachnoid cysts
• Echocardiogram - for cardiac anomaly screening

Genetic Testing and Family Screening

Genetic testing for PITX2 and FOXC1 mutations should be performed to:

• Confirm diagnosis
• Provide gene-specific prognosis and management
• Enable family counseling (autosomal dominant inheritance) 6, 7

Screen children of affected parents as soon as possible - ideally within the first year of life to improve early diagnosis and glaucoma prognosis 3.

Treatment Priorities

Glaucoma Management

• Medical management with antiglaucoma medications as first-line 8
• Surgical intervention when medical therapy fails (trabeculectomy, tube shunt procedures)
• Goal: prevent irreversible optic nerve damage and vision loss

Amblyopia Prevention

• Correct significant refractive errors promptly 4
• Treat amblyopia aggressively if present (patching, atropine penalization)
• Regular visual acuity monitoring

Systemic Anomaly Management

• Coordinate care with appropriate specialists based on identified anomalies
• Early dental intervention to optimize oral development 3

Long-Term Follow-Up

Lifelong ophthalmologic surveillance is mandatory due to:

• Progressive nature of glaucoma risk
• Potential for late-onset complications
• Need for ongoing refractive management

The distinction between PITX2-related ARS and FOXC1-related ARS is clinically critical as they have distinct systemic phenotypes requiring different screening protocols 7.